MAAT INDEX

CLAIM #58996 · UnitedHealth Group Incorporated (UNH) · 2026Q1 earnings call · Apr 21, 2026 · due Dec 31, 2026

This pattern also similarly influences the progression of our medical cost ratio with first half levels more than 250 basis points below the midpoint of our full year guidance and second half levels more than 200 basis points above.

Wayne DeVeydt · CFO

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: UnitedHealthcare medical cost ratio (MCR) for first half 2026 vs. full year 2026 guidance midpoint, and second half 2026 vs. same midpoint

It came true if: First half MCR at least 250 basis points below the midpoint of full year 2026 MCR guidance, AND second half MCR at least 200 basis points above that same midpoint

Where: Company quarterly earnings releases/10-Q and 10-K disclosures of medical cost ratio (Q2 2026 and full year 2026 results)

In context

ance we saw in the first quarter with a prudent level of patience to see how the remaining months evolve. Our earnings cadence for the year remains consistent with prior expectations. We continue to expect approximately 2/3 of earnings in the first half of the year and the remaining 1/3 in the second half. That said, the earnings profile varies meaningfully across the portfolio. UnitedHealthcare earnings are over 75% weighted to the first half of the year. Similarly, for Optum Health, we expect earnings to moderate throughout the year from Q1 levels with a significant majority of full year reported earnings occurring in the first half. In contrast, Optum Insight and Optum Rx are more naturally weighted to the back half with each generating approximately 60% of earnings in the second half. This pattern also similarly influences the progression of our medical cost ratio with first half levels more than 250 basis points below the midpoint of our full year guidance and second half levels more than 200 basis points above. Overall, this has been a strong start to the year as we continue to improve our business performance and advance our mission. Steve, back to you. Stephen Hemsley: Thanks, Wayne. Before we turn to your questions, let me kind of summarize where I think our company stands today. This was a solid quarter across all segments, positioning us for similarly solid progress going forward. The historic disciplines and innovations of UnitedHealthcare are rounding back into place. Optum Health is clearly focusing on the right basic elements and gaining traction. Optum Insight has untapped potential in an AI-centric world. They're starting to sell business and building broader service relationships around that reality, but to evolve more modern scale solutions and for users to be ready to embrace them,

Verify independently

SEC filings for UNH · Claim quote is verbatim from the 2026Q1 earnings call.